Compare Redwire Corporation (RDW) vs Zoetis Inc (ZTS) Price & Performance

Redwire CorporationTrade

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Redwire Corporation vs Zoetis Inc — how do they compare? Redwire Corporation trades at $9.09 (market cap $2.25B), while Zoetis Inc trades at $74.6 (market cap $31.59B). The key difference: Zoetis Inc is far larger — about 14× Redwire Corporation's market cap, and Zoetis Inc pays a 2.81% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals.

	RDW	ZTS
Market Cap	$2.25B	$31.59B
Sector	Technology	Health
52-Week High	$25.90	$156.76
52-Week Low	$5.06	$71.91
Enterprise Value	$2.31B	$38.89B
Dividend Yield	—	2.81%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RDW

Redwire Corp rated Hold with $9 target, citing execution risks and flat growth despite strong backlog.Seeking Alpha · 1 day agoNeutral Redwire gains investor interest with strong backlog and major contracts despite recent revenue missSeeking Alpha · 1 day agoBullish Redwire shifts to stronger execution with $498M backlog and improved margins, signaling growth potential.Seeking Alpha · 4 days agoBullish View details →

ZTS

View details →

About Redwire Corporation

Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.